Skip to content
★ Sign in to follow
Miahelsa Holdings Corporation logo

Miahelsa Holdings Corporation Stock: price and insider trades · Japan

ミアヘルサホールディングス株式会社

JP·Mcap JP¥3.1BHealth Care

Miahelsa Holdings Corporation: what insiders have been doing

Every trade that managers of Miahelsa Holdings Corporation disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. 4 insiders have disclosed 4 filings since 26 October 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

There has been no open-market purchase by an insider of Miahelsa Holdings Corporation for at least a year. Filings reach the EDINET (Japan FSA) feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade.

For context, the typical company on the same exchange (median of 3,205 companies) published 3 filings over the same period, against 4 filings here. The full history, which starts in 2021, counts no purchases against 45 sales.

These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.

Insider Decl.
67
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€61,711
45 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,068 of 26,911 companies
50.2
score / 100
Value
75
Quality
25
FCF yld16%
Earn yld6.4%
EV/EBITDA8.4x
ROE4.6%
Gross mgn11%
Net mgn0.8%
Debt/EBITDA5.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥1,121
Analyst consensus
·
Income statement
RevenueJP¥24.9B
Gross profitJP¥2.7B11% margin
EBITDAJP¥1.1B4% margin
Net incomeJP¥200.9M0.7% margin
Valuation
PER (trailing)17.7x
P/Book0.8x
Beta0.13
Balance sheet & cash
Market capJP¥3.1B
Total debtJP¥5.9B
Free Cash FlowJP¥513.8M
Debt / Equity76%
Profitability & ownership
ROE4.6%
ROA3.8%
% insiders61.5%
% institutions0.3%
Last declaration on 2 October 2026
Declarations67 total

25 of 67 declarations

About Miahelsa Holdings Corporation

Miahelsa Holdings Inc. is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.